Review decisions

Showing 110 results of 287 total
Summary Safety Review - Sunscreen products - Assessing the potential risk of skin reactions
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00211
Issued / Original Publication Date: 2018-11-26
Updated Date: 2020-06-26
Summary Safety Review - JAKAVI (ruxolitinib) - Assessing the potential risk of drug interactions with P-glycoprotein (P-gp) substrates (including rosuvastatin)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00212
Issued / Original Publication Date: 2018-10-09
Summary Safety Review - Beta-lactam antibiotics - Assessing the potential risk of severe skin side effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00209
Issued / Original Publication Date: 2018-09-10
Summary Safety Review - Fibristal (5 mg ulipristal acetate) - Assessing the potential risk of rare but serious liver injury
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00210
Issued / Original Publication Date: 2018-09-07
Summary Safety Review - Oral prednisone and prednisolone (glucocorticoids) - Assessing the potential risk of a serious complication called scleroderma renal crisis in patients with systemic sclerosis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00208
Issued / Original Publication Date: 2018-08-07
Summary Safety Review - METHADOSE and METADOL-D - Assessing the potential risk of serious harm in children exposed to methadone through breast milk
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00207
Issued / Original Publication Date: 2018-08-03
Summary Safety Review - IMBRUVICA (ibrutinib) - Assessing the potential risk of a serious and life-threatening abnormal heart rhythm (ventricular tachyarrhythmia)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00206
Issued / Original Publication Date: 2018-07-26
Summary Safety Review - REMICADE (infliximab) - Assessing the potential risk of a blistering skin condition known as linear IgA bullous dermatosis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00205
Issued / Original Publication Date: 2018-07-23
Summary Safety Review - Sodium/glucose cotransporter 2 (SGLT2) inhibitors - Assessing the potential risk of inflammation of the pancreas (acute and chronic pancreatitis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00204
Issued / Original Publication Date: 2018-07-20
Summary Safety Review - Imatinib mesylate (GLEEVEC and generics) - Assessing the potential risk of tendon disorders
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00202
Issued / Original Publication Date: 2018-06-08

Displaying 101 - 110 of 287 | Page 11 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: